Skip to main content
Fig. 10 | BMC Medical Genomics

Fig. 10

From: Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature

Fig. 10

Prediction of response to immunotherapy. (A) In comparison to C1, C2 showed a higher risk score. (B-C) Difference in ICI- and HLA-related genes between clusters. (D) IPS score predicting immunotherapy response. ICI, immune checkpoint inhibitor; HLA, human leukocyte antigen; IPS, immunophenoscore. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page